Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Bronchial colonization and complications after lung cancer surgery.

Oor JE, Daniels JM, Debets-Ossenkopp YJ, de Lange-de Klerk ES, Oosterhuis JW, Dickhoff C, Hartemink KJ.

Langenbecks Arch Surg. 2016 Sep;401(6):885-92. doi: 10.1007/s00423-016-1487-z. Epub 2016 Aug 2.

PMID:
27485548
2.

Galactomannan detection for invasive aspergillosis in immunocompromised patients.

Leeflang MM, Debets-Ossenkopp YJ, Wang J, Visser CE, Scholten RJ, Hooft L, Bijlmer HA, Reitsma JB, Zhang M, Bossuyt PM, Vandenbroucke-Grauls CM.

Cochrane Database Syst Rev. 2015 Dec 30;(12):CD007394. doi: 10.1002/14651858.CD007394.pub2. Review.

3.

Microbiological findings and adequacy of antibiotic treatment in the critically ill patient with drowning-associated pneumonia.

Assink-de Jong E, Douma M, Beishuizen A, Hoogewerf M, Debets-Ossenkopp YJ, de Waard MC, Girbes AR.

Intensive Care Med. 2014 Feb;40(2):290-1. doi: 10.1007/s00134-013-3175-6. Epub 2013 Dec 6. No abstract available.

PMID:
24310849
4.

Prosthetic joint-associated infections treated with DAIR (debridement, antibiotics, irrigation, and retention): analysis of risk factors and local antibiotic carriers in 91 patients.

Kuiper JW, Vos SJ, Saouti R, Vergroesen DA, Graat HC, Debets-Ossenkopp YJ, Peters EJ, Nolte PA.

Acta Orthop. 2013 Aug;84(4):380-6. doi: 10.3109/17453674.2013.823589. Epub 2013 Jul 12.

5.

Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.

van der Linden JW, Camps SM, Kampinga GA, Arends JP, Debets-Ossenkopp YJ, Haas PJ, Rijnders BJ, Kuijper EJ, van Tiel FH, Varga J, Karawajczyk A, Zoll J, Melchers WJ, Verweij PE.

Clin Infect Dis. 2013 Aug;57(4):513-20. doi: 10.1093/cid/cit320. Epub 2013 May 10.

PMID:
23667263
6.

Old and new biomarkers for predicting high and low risk microbial infection in critically ill patients with new onset fever: a case for procalcitonin.

Hoeboer SH, Alberts E, van den Hul I, Tacx AN, Debets-Ossenkopp YJ, Groeneveld AB.

J Infect. 2012 May;64(5):484-93. doi: 10.1016/j.jinf.2012.01.002. Epub 2012 Jan 8.

PMID:
22248983
7.

A rare pulmonary infection caused by Arthrographis kalrae.

Vos CG, Murk JL, Hartemink KJ, Daniels JM, Paul MA, Debets-Ossenkopp YJ.

J Med Microbiol. 2012 Apr;61(Pt 4):593-5. doi: 10.1099/jmm.0.037531-0. Epub 2011 Dec 8.

PMID:
22160311
8.

Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009.

van der Linden JW, Snelders E, Kampinga GA, Rijnders BJ, Mattsson E, Debets-Ossenkopp YJ, Kuijper EJ, Van Tiel FH, Melchers WJ, Verweij PE.

Emerg Infect Dis. 2011 Oct;17(10):1846-54. doi: 10.3201/eid1710.110226.

9.

Efficacy of serology driven "test and treat strategy" for eradication of H. pylori in patients with rheumatic disease in the Netherlands.

de Leest HT, Steen KS, Lems WF, van de Laar MA, Huisman AM, Kadir SW, Houben HH, Kostense PJ, Kuipers EJ, Dijkmans BA, Debets-Ossenkopp YJ.

Eur J Clin Microbiol Infect Dis. 2011 Jul;30(7):903-8. doi: 10.1007/s10096-011-1174-5. Epub 2011 Feb 4.

10.

Characterization of DIM-1, an integron-encoded metallo-beta-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands.

Poirel L, Rodríguez-Martínez JM, Al Naiemi N, Debets-Ossenkopp YJ, Nordmann P.

Antimicrob Agents Chemother. 2010 Jun;54(6):2420-4. doi: 10.1128/AAC.01456-09. Epub 2010 Mar 22.

11.

Characterization of fluoroquinolone resistance in a clinical isolate of Pseudomonas stutzeri.

Rodríguez-Martínez JM, Poirel L, Al Naiemi N, Debets-Ossenkopp YJ, Nordmann P.

J Antimicrob Chemother. 2010 Feb;65(2):366-7. doi: 10.1093/jac/dkp441. Epub 2009 Dec 14. No abstract available.

PMID:
20008448
12.

Emergence of metallo-beta-lactamases in the Netherlands.

al Naiemi N, Rijnsburger MC, Savelkoul PH, Vandenbroucke-Grauls CM, Debets-Ossenkopp YJ.

J Med Microbiol. 2009 Oct;58(Pt 10):1398-9. doi: 10.1099/jmm.0.011874-0. Epub 2009 Jul 2. No abstract available.

PMID:
19574411
13.

Enrichment broth improved detection of extended-spectrum-beta-lactamase-producing bacteria in throat and rectal surveillance cultures of samples from patients in intensive care units.

Murk JL, Heddema ER, Hess DL, Bogaards JA, Vandenbroucke-Grauls CM, Debets-Ossenkopp YJ.

J Clin Microbiol. 2009 Jun;47(6):1885-7. doi: 10.1128/JCM.01406-08. Epub 2009 Apr 22.

14.

Extended-spectrum beta-lactamases screening agar with AmpC inhibition.

Naiemi NA, Murk JL, Savelkoul PH, Vandenbroucke-Grauls CM, Debets-Ossenkopp YJ.

Eur J Clin Microbiol Infect Dis. 2009 Aug;28(8):989-90. doi: 10.1007/s10096-009-0714-8. Epub 2009 Feb 20. No abstract available.

15.

Galactomannan detection for invasive aspergillosis in immunocompromized patients.

Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Scholten RJ, Hooft L, Bijlmer HA, Reitsma JB, Bossuyt PM, Vandenbroucke-Grauls CM.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD007394. doi: 10.1002/14651858.CD007394. Review. Update in: Cochrane Database Syst Rev. 2015;12:CD007394.

PMID:
18843747
16.

Extended-spectrum-beta-lactamase production in a Salmonella enterica serotype Typhi strain from the Philippines.

Al Naiemi N, Zwart B, Rijnsburger MC, Roosendaal R, Debets-Ossenkopp YJ, Mulder JA, Fijen CA, Maten W, Vandenbroucke-Grauls CM, Savelkoul PH.

J Clin Microbiol. 2008 Aug;46(8):2794-5. doi: 10.1128/JCM.00676-08. Epub 2008 Jun 11.

17.

Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients.

Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, Girbes AR, Groeneveld AB.

Intensive Care Med. 2007 Oct;33(10):1694-703. Epub 2007 Jul 24. Review.

18.

Meta-analysis of diagnostic test accuracy.

Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Bossuyt PM.

Clin Infect Dis. 2006 Nov 1;43(9):1220; author reply 1220-1. No abstract available.

PMID:
17029148
19.

Widely distributed and predominant CTX-M extended-spectrum beta-lactamases in Amsterdam, The Netherlands.

al Naiemi N, Bart A, de Jong MD, Vandenbroucke-Grauls CM, Rietra PJ, Debets-Ossenkopp YJ, Wever PC, Spanjaard L, Bos AJ, Duim B.

J Clin Microbiol. 2006 Aug;44(8):3012-4.

20.

Successful treatment with linezolid and rifampicin of meningitis due to methicillin-resistant Staphylococcus epidermidis refractory to vancomycin treatment.

Kruse AJ, Peerdeman SM, Bet PM, Debets-Ossenkopp YJ.

Eur J Clin Microbiol Infect Dis. 2006 Feb;25(2):135-7. No abstract available.

PMID:
16474940
21.

[Resistant microorganisms in patients transferred from foreign hospitals].

Kaiser AM, Schultsz C, Kruithof GJ, Debets-Ossenkopp YJ, Vandenbroucke-Grauls CM.

Ned Tijdschr Geneeskd. 2005 Oct 29;149(44):2459-64. Dutch.

PMID:
16285362
22.

Zygomycete infection following voriconazole prophylaxis.

van Well GT, van Groeningen I, Debets-Ossenkopp YJ, van Furth AM, Zwaan CM.

Lancet Infect Dis. 2005 Sep;5(9):594. No abstract available.

PMID:
16122683
23.

Characteristics of clinical Helicobacter pylori strains from Ecuador.

Debets-Ossenkopp YJ, Reyes G, Mulder J, aan de Stegge BM, Peters JT, Savelkoul PH, Tanca J, Peña AS, Vandenbroucke-Grauls CM.

J Antimicrob Chemother. 2003 Jan;51(1):141-5.

PMID:
12493799
24.

Superior antimicrobial activity of trisodium citrate over heparin for catheter locking.

Weijmer MC, Debets-Ossenkopp YJ, Van De Vondervoort FJ, ter Wee PM.

Nephrol Dial Transplant. 2002 Dec;17(12):2189-95.

PMID:
12454232
25.

Nosocomial spread of a Staphylococcus capitis strain with heteroresistance to vancomycin in a neonatal intensive care unit.

Van Der Zwet WC, Debets-Ossenkopp YJ, Reinders E, Kapi M, Savelkoul PH, Van Elburg RM, Hiramatsu K, Vandenbroucke-Grauls CM.

J Clin Microbiol. 2002 Jul;40(7):2520-5.

26.

Cerebellar and medullar histoplasmosis.

Vos MJ, Debets-Ossenkopp YJ, Claessen FA, Hazenberg GJ, Heimans JJ.

Neurology. 2000 Apr 11;54(7):1441. No abstract available.

PMID:
10798952
27.

[Manifestations of histoplasmosis].

Claessen FA, Vos MJ, Simoons-Smit AM, Debets-Ossenkopp YJ, Perenboom RM.

Ned Tijdschr Geneeskd. 2000 Jun 17;144(25):1201-5. Review. Dutch.

PMID:
10897298
28.

Occurrence of extended-spectrum betalactamases (ESBL) in Dutch hospitals.

Stobberingh EE, Arends J, Hoogkamp-Korstanje JA, Goessens WH, Visser MR, Buiting AG, Debets-Ossenkopp YJ, van Ketel RJ, van Ogtrop ML, Sabbe LJ, Voorn GP, Winter HL, van Zeijl JH.

Infection. 1999 Nov-Dec;27(6):348-54.

PMID:
10624595
29.

Insertion of mini-IS605 and deletion of adjacent sequences in the nitroreductase (rdxA) gene cause metronidazole resistance in Helicobacter pylori NCTC11637.

Debets-Ossenkopp YJ, Pot RG, van Westerloo DJ, Goodwin A, Vandenbroucke-Grauls CM, Berg DE, Hoffman PS, Kusters JG.

Antimicrob Agents Chemother. 1999 Nov;43(11):2657-62.

30.

Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance.

van Doorn LJ, Debets-Ossenkopp YJ, Marais A, Sanna R, Mégraud F, Kusters JG, Quint WG.

Antimicrob Agents Chemother. 1999 Jul;43(7):1779-82.

31.

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands.

Debets-Ossenkopp YJ, Herscheid AJ, Pot RG, Kuipers EJ, Kusters JG, Vandenbroucke-Grauls CM.

J Antimicrob Chemother. 1999 Apr;43(4):511-5.

PMID:
10350380
32.

Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori.

Debets-Ossenkopp YJ, Brinkman AB, Kuipers EJ, Vandenbroucke-Grauls CM, Kusters JG.

Antimicrob Agents Chemother. 1998 Oct;42(10):2749-51.

33.

Detection of antigen in sera of patients with invasive aspergillosis: intra- and interlaboratory reproducibility. The Dutch Interuniversity Working Party for Invasive Mycoses.

Verweij PE, Erjavec Z, Sluiters W, Goessens W, Rozenberg-Arska M, Debets-Ossenkopp YJ, Guiot HF, Meis JF.

J Clin Microbiol. 1998 Jun;36(6):1612-6.

34.

Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori.

Debets-Ossenkopp YJ, Sparrius M, Kusters JG, Kolkman JJ, Vandenbroucke-Grauls CM.

FEMS Microbiol Lett. 1996 Aug 15;142(1):37-42.

PMID:
8759787
35.

Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents.

Debets-Ossenkopp YJ, Namavar F, MacLaren DM.

Eur J Clin Microbiol Infect Dis. 1995 Apr;14(4):353-5.

PMID:
7649202

Supplemental Content

Loading ...
Support Center